Literature DB >> 23046134

Structural insights into activation of antiviral NK cell responses.

Kathryn A Finton1, Roland K Strong.   

Abstract

Natural killer (NK) cells are key components of innate immune responses, providing surveillance against cells undergoing tumorigenesis or infection, by viruses or internal pathogens. NK cells can directly eliminate compromised cells and regulate downstream responses of the innate and acquired immune systems through the release of immune modulators (cytokines, interferons). The importance of the role NK cells play in immune defense was demonstrated originally in herpes viral infections, usually mild or localized, which become severe and life threatening in NK-deficient patients . NK cell effector functions are governed by balancing opposing signals from a diverse array of activating and inhibitory receptors. Many NK receptors occur in paired activating and inhibitory isoforms and recognize major histocompatibility complex (MHC) class I proteins with varying degrees of peptide specificity. Structural studies have made considerable inroads into understanding the molecular mechanisms employed to broadly recognize multiple MHC ligands or specific pathogen-associated antigens and the strategies employed by viruses to thwart these defenses. Although many details of NK development, signaling, and integration remain mysterious, it is clear that NK receptors are key components of a system exquisitely tuned to sense any dysregulation in MHC class I expression, or the expression of certain viral antigens, resulting in the elimination of affected cells.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23046134      PMCID: PMC3471384          DOI: 10.1111/j.1600-065X.2012.01168.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  184 in total

1.  Structural studies of allelic diversity of the MHC class I homolog MIC-B, a stress-inducible ligand for the activating immunoreceptor NKG2D.

Authors:  Margaret A Holmes; Pingwei Li; Effie W Petersdorf; Roland K Strong
Journal:  J Immunol       Date:  2002-08-01       Impact factor: 5.422

2.  Finding the groove.

Authors:  Pamela J Bjorkman
Journal:  Nat Immunol       Date:  2006-08       Impact factor: 25.606

Review 3.  Polyspecificity of T cell and B cell receptor recognition.

Authors:  Kai W Wucherpfennig; Paul M Allen; Franco Celada; Irun R Cohen; Rob De Boer; K Christopher Garcia; Byron Goldstein; Ralph Greenspan; David Hafler; Philip Hodgkin; Erik S Huseby; David C Krakauer; David Nemazee; Alan S Perelson; Clemencia Pinilla; Roland K Strong; Eli E Sercarz
Journal:  Semin Immunol       Date:  2007-03-29       Impact factor: 11.130

4.  Binding of a soluble p70 killer cell inhibitory receptor to HLA-B*5101: requirement for all three p70 immunoglobulin domains.

Authors:  S Rojo; N Wagtmann; E O Long
Journal:  Eur J Immunol       Date:  1997-02       Impact factor: 5.532

5.  Crystal structure of the HLA-Cw3 allotype-specific killer cell inhibitory receptor KIR2DL2.

Authors:  G A Snyder; A G Brooks; P D Sun
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

6.  Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus.

Authors:  Tal I Arnon; Hagit Achdout; Ofer Levi; Gal Markel; Nivin Saleh; Gil Katz; Roi Gazit; Tsufit Gonen-Gross; Jacob Hanna; Efrat Nahari; Angel Porgador; Alik Honigman; Bodo Plachter; Dror Mevorach; Dana G Wolf; Ofer Mandelboim
Journal:  Nat Immunol       Date:  2005-04-10       Impact factor: 25.606

7.  Structure of the inhibitory receptor for human natural killer cells resembles haematopoietic receptors.

Authors:  Q R Fan; L Mosyak; C C Winter; N Wagtmann; E O Long; D C Wiley
Journal:  Nature       Date:  1997-09-04       Impact factor: 49.962

8.  Complexes of HLA-G protein on the cell surface are important for leukocyte Ig-like receptor-1 function.

Authors:  Tsufit Gonen-Gross; Hagit Achdout; Roi Gazit; Jacob Hanna; Sa'ar Mizrahi; Gal Markel; Debra Goldman-Wohl; Simcha Yagel; Václav Horejsí; Ofer Levy; Michal Baniyash; Ofer Mandelboim
Journal:  J Immunol       Date:  2003-08-01       Impact factor: 5.422

9.  Dimorphic motifs in D0 and D1+D2 domains of killer cell Ig-like receptor 3DL1 combine to form receptors with high, moderate, and no avidity for the complex of a peptide derived from HIV and HLA-A*2402.

Authors:  Deepti Sharma; Karine Bastard; Lisbeth A Guethlein; Paul J Norman; Nobuyo Yawata; Makoto Yawata; Marcelo Pando; Hathairat Thananchai; Tao Dong; Sarah Rowland-Jones; Frances M Brodsky; Peter Parham
Journal:  J Immunol       Date:  2009-09-14       Impact factor: 5.422

10.  Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner.

Authors:  Golo Ahlenstiel; Rachel H Titerence; Christopher Koh; Birgit Edlich; Jordan J Feld; Yaron Rotman; Marc G Ghany; Jay H Hoofnagle; T Jake Liang; Theo Heller; Barbara Rehermann
Journal:  Gastroenterology       Date:  2009-09-10       Impact factor: 22.682

View more
  12 in total

1.  The structure of the atypical killer cell immunoglobulin-like receptor, KIR2DL4.

Authors:  Shoeib Moradi; Richard Berry; Phillip Pymm; Corinne Hitchen; Simone A Beckham; Matthew C J Wilce; Nicholas G Walpole; Craig S Clements; Hugh H Reid; Matthew A Perugini; Andrew G Brooks; Jamie Rossjohn; Julian P Vivian
Journal:  J Biol Chem       Date:  2015-03-10       Impact factor: 5.157

2.  Transfection of chimeric anti-CD138 gene enhances natural killer cell activation and killing of multiple myeloma cells.

Authors:  Hua Jiang; Wenhao Zhang; Peipei Shang; Hui Zhang; Weijun Fu; Fei Ye; Tianmei Zeng; Hejing Huang; Xueguang Zhang; Wanping Sun; Daniel Man-Yuen Sze; Qing Yi; Jian Hou
Journal:  Mol Oncol       Date:  2013-12-12       Impact factor: 6.603

3.  The transcription factor RUNX2 drives the generation of human NK cells and promotes tissue residency.

Authors:  Sigrid Wahlen; Filip Matthijssens; Wouter Van Loocke; Sylvie Taveirne; Laura Kiekens; Eva Persyn; Els Van Ammel; Zenzi De Vos; Stijn De Munter; Patrick Matthys; Filip Van Nieuwerburgh; Tom Taghon; Bart Vandekerckhove; Pieter Van Vlierberghe; Georges Leclercq
Journal:  Elife       Date:  2022-07-06       Impact factor: 8.713

4.  Insights into immune structure, recognition, and signaling.

Authors:  K Christopher Garcia
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

5.  ARTEMIS: A Novel Mass-Spec Platform for HLA-Restricted Self and Disease-Associated Peptide Discovery.

Authors:  Kathryn A K Finton; Mi-Youn Brusniak; Lisa A Jones; Chenwei Lin; Andrew J Fioré-Gartland; Chance Brock; Philip R Gafken; Roland K Strong
Journal:  Front Immunol       Date:  2021-04-23       Impact factor: 7.561

Review 6.  Structural basis for recognition of cellular and viral ligands by NK cell receptors.

Authors:  Yili Li; Roy A Mariuzza
Journal:  Front Immunol       Date:  2014-03-26       Impact factor: 7.561

7.  HLA-F and MHC-I Open Conformers Bind Natural Killer Cell Ig-Like Receptor KIR3DS1.

Authors:  Aura Burian; Kevin L Wang; Kathryn A K Finton; Ni Lee; Akiko Ishitani; Roland K Strong; Daniel E Geraghty
Journal:  PLoS One       Date:  2016-09-20       Impact factor: 3.240

8.  The interaction of KIR3DL1*001 with HLA class I molecules is dependent upon molecular microarchitecture within the Bw4 epitope.

Authors:  Philippa M Saunders; Julian P Vivian; Nikola Baschuk; Travis Beddoe; Jacqueline Widjaja; Geraldine M O'Connor; Corinne Hitchen; Phillip Pymm; Daniel M Andrews; Stephanie Gras; Daniel W McVicar; Jamie Rossjohn; Andrew G Brooks
Journal:  J Immunol       Date:  2014-12-05       Impact factor: 5.422

Review 9.  NK Cells during Dengue Disease and Their Recognition of Dengue Virus-Infected cells.

Authors:  Davis Beltrán; Sandra López-Vergès
Journal:  Front Immunol       Date:  2014-05-05       Impact factor: 7.561

Review 10.  Leukocyte Ig-Like Receptors - A Model for MHC Class I Disease Associations.

Authors:  Laura Emily Hudson; Rachel Louise Allen
Journal:  Front Immunol       Date:  2016-07-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.